Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Long-Term Investments

Arbutus Biopharma Cp Long-Term Investments Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Long-Term Investments from 2014 to 2018.
  • Arbutus Biopharma Cp Long-Term Investments for the quarter ending December 12, 2018 was $22m a 54.51% increase of 12m year over year
  • Arbutus Biopharma Cp Long-Term Investments for the last 12 months ending December 12, 2018 was $22m a 54.51% increase of 12m year over year
  • Arbutus Biopharma Cp Annual Long-Term Investments for 2018 was $22m a 54.64% increase of 12m from 2017
  • Arbutus Biopharma Cp Annual Long-Term Investments for 2015 was $10m
Other Cash Flow Metrics:
  • Arbutus Biopharma Cp Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a -16.70% increase of 3m year over year
  • Arbutus Biopharma Cp Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-36m a 63.34% decrease of -23m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Long-Term Investments Data

12/2018$22m
09/2018$25m
06/2018$27m
03/2016$10m
12/2015$10m
09/2015$10m
06/2015$10m
09/2014$12m
06/2014$12m

Annual ABUS Long-Term Investments Data

2018$22m
2015$10m